Organon Pharma Indonesia Tbk. vs Pabrik Kertas Tjiwi Kimia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Pabrik Kertas Tjiwi Kimia Tbk. trades at Rp7,850 (market cap 24.83T, 4.14M 24h volume). The key difference: Pabrik Kertas Tjiwi Kimia Tbk. is far larger — about 237.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TKIM | |
|---|---|---|
Market Cap | 104.4B | 24.83T |
Volume | — | 4.14M |
Lot | — | 41.35K |
Turnover | — | 32.31B |
Average Price | — | 7,813.32 |
Value | — | 32.31B |
Indicative Equilibrium Price | — | 7,850 |
Indicative Equilibrium Volume | — | 421 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Pabrik Kertas Tjiwi Kimia Tbk (the Company) was established in 1972 under the name of PT Tjiwi Kimia and was later renamed to become PT Pabrik Kertas Tjiwi Kimia in 1974. The total production capacity as of December 31, 1999 for the printing and writing paper stood at 1.014.000 tonnes per annum, packaging and converted products at 78.000 tonnes per annum and stationery at 275.000 tonnes per annum.The Company started its commercial production in 1977.
Read more on TKIM →